CI&T (NYSE:CINT) Q4 2025 Earnings call March 11, 2026 04:30 PM ET Speaker4Good afternoon, and thank you for joining us for CI&T fourth quarter and full year 2025 earnings call. I am Eduardo Galvão, Director of Investor Relations. Joining me today to discuss our results and strategic milestones are Cesar Gon, our Founder and CEO, Bruno Guicardi, Founder and President for North America and Europe, and Stanley Rodrigues, our CFO. We're excited to share the details of a landmark year for the company. Before we ...

Financial Data and Key Metrics Changes - For the full year 2025, Sonida's net operating income increased by more than 22% and adjusted EBITDA at share improved by 28% [8][18] - The company realized a 5.9% increase in revenue per occupied room (RevPOR) for Q4 compared to the same quarter in the prior year, with an annual growth of 8.8% [18][20] - The total portfolio NOI at share grew by 22% or $15 million on an annualized basis [20] Business Line Data and Key Metrics Changes - The same-store portfolio saw an additional 20 basis points of sequential occupancy gains in Q4, following a 90 basis points increase in Q3 [18] - The acquisition portfolio experienced a 680 basis point occupancy jump from 2024, with community NOI margin expanding by 550 basis points to 24.7% [19] - The 19 communities acquired in 2024 showed a sequential occupancy improvement of 290 basis points from Q3 to Q4, with total occupancy improving by 820 basis points year-over-year [9] Market Data and Key Metrics Changes - The company anticipates accelerated occupancy gains as the 19 communities from the 2024 acquisition cohort move into the same-store portfolio in 2026 [18] - The average annual rent renewal rate on in-place leases for the recent March 1 renewal was 7.9%, up from 6.8% the previous year [25] Company Strategy and Development Direction - The company completed the acquisition of CNL Healthcare Properties for a total consideration of $1.8 billion, enhancing competitive positioning and growth profile [5][6] - Sonida plans to prune approximately 10% of its portfolio based on community count to recycle capital into higher growth, newer vintage assets [22][39] - The focus will be on delivering excellent clinical care and services while developing a labor model that rewards strong employees [10][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the merger's potential to drive improved performance trends and significant upside [10] - The company is committed to retaining and developing talent, with a focus on reducing employee turnover [16] - Management highlighted the importance of operational performance and advanced technology platforms to improve resident outcomes and efficiency [17] Other Important Information - The company has reached an agreement for the early conversion of Series A convertible preferred stock into common equity, simplifying its capital structure and reducing costs [14][15] - The commitment of a new upsized $405 million revolver will increase available capital for investment opportunities [13] Q&A Session Summary Question: Can you discuss the adjusted EBITDA and interest costs post-merger? - Management indicated that details will be provided in Q1, aiming for comparability with large-scale REIT reporters [36] Question: What is the timeline for pruning the 10% of the portfolio? - Management expects to make progress within 6 to 12 months, with proceeds first going to de-lever the company [39] Question: Is the 16%+ same-store NOI growth a good run rate number? - Management views it as a starting point and will provide more insights as they release normalized FFO metrics [40][41] Question: Is the 7.9% rate increase for the legacy pool or the current pool? - The rate increase is for the legacy pool that was pushed through recently [45] Question: Will net lease assets be part of the dispositions this year? - Management stated there are no immediate plans for net lease assets but will evaluate market opportunities [50]

Financial Data and Key Metrics Changes - For Q4 2025, revenue increased by 17% year-over-year to $397.6 million, with organic growth at 12% [15] - Adjusted EBITDA grew 53% year-over-year to $39.5 million, with margins expanding to 9.9% [18] - Full-year adjusted EBITDA for 2025 was $115 million, exceeding guidance of $104 million-$106 million [20] - The company increased its cash balance to $66 million, up from $36 million in the previous quarter [18] Business Line Data and Key Metrics Changes - The company served over 205,000 residents, a 10% increase year-over-year [15] - Script volume grew by 14% year-over-year, with vaccine script volumes up 3% [15][16] - Gross profit rose 27% to $85.5 million, with gross margins expanding to 21.5% from 19.8% [15] Market Data and Key Metrics Changes - The company anticipates a revenue forecast of $1.4 billion-$1.42 billion for 2026, reflecting new pricing from the IRA [13][21] - The long-term care pharmacy environment is evolving with ongoing consolidation and increasing operational complexity [10] Company Strategy and Development Direction - The company plans to offset anticipated EBITDA impacts from the IRA in 2026 and is focused on maintaining service levels and cash flow [9][10] - The company is actively engaged in discussions for potential acquisitions and greenfield startups to expand its operational footprint [19][53] - The company aims to balance profit contributions between generics and branded drugs, with 92% of prescriptions being generic [30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth momentum despite industry changes, with a focus on durable growth and margin expansion [12][13] - The demographic shift with the aging population is expected to create a tailwind for the company [10] - Management acknowledged the challenges posed by the IRA but believes the company's scale and operational discipline will provide stability [10] Other Important Information - The company performed over 100,000 clinical interventions benefiting approximately 74,000 residents, demonstrating its operational and clinical value [6] - The company administered over 120,000 vaccines during the third and fourth quarters, with improved profitability year-over-year [8] Q&A Session Summary Question: Can you help us understand what's durable, what's vaccine, what's non-recurring in the quarter? - Management indicated that the run rate for EBITDA is approximately $110 million, with variability in Q4 not projected to continue [26] Question: Did the vaccine program contribute more this year than last year? - Management confirmed that the vaccine program continued to be significant in Q4, with improved reimbursement and profitability [28] Question: What were you able to get done from a contracting standpoint to better balance the two profit streams? - Management noted progress in aligning gross margin dollars with the high volume of generic prescriptions [30] Question: Is the gap between potential margin and realized margin still what it was a couple of quarters ago? - Management indicated that the gap has increased to approximately 90 basis points, reflecting investments for future profitability [31] Question: Can you discuss the opportunity around share gain with struggling competitors? - Management acknowledged potential opportunities arising from competitors facing challenges, particularly in the context of bankruptcy [42] Question: Are you seeing efficiencies and improvements in labor inflation? - Management clarified that efficiencies are primarily due to scaling the existing platform rather than improvements in labor inflation [43]

Petco Health and Wellness Company (NasdaqGS:WOOF) Q4 2026 Earnings call March 11, 2026 04:30 PM ET Speaker6Good afternoon, and welcome to the Petco fourth quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw you ...

Frequency Electronics (NasdaqGM:FEIM) Q3 2026 Earnings call March 11, 2026 04:30 PM ET Speaker3Greetings, and welcome to the Frequency Electronics third quarter fiscal 2026 earnings release conference call. At this time, all participants are on a listen-only mode. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. Any statements made by the company during this conference call regarding the fut ...

Bumble (NasdaqGS:BMBL) Q4 2025 Earnings call March 11, 2026 04:30 PM ET Speaker5I would now like to hand over to Will Taveras, Investor Relations. Please go ahead.Speaker9Thank you for joining us to discuss Bumble's fourth quarter and full year 2025 financial results. With me today are Bumble's founder and CEO, Whitney Wolfe Herd, and CFO, Kevin Cook. Before we begin, I'd like to remind everyone that certain statements made on this call today are forward-looking statements. These forward-looking statements ...

Financial Data and Key Metrics Changes - The company ended the year with $123.9 million in cash, driven largely by the successful closing of 4.75% convertible senior notes [8] - The average cash cost per pound sold was $42.89, reflecting improved operational efficiency [5] - The company achieved a positive gross profit of $74,000, marking an encouraging milestone as operations and production continue to improve [9] Business Line Data and Key Metrics Changes - At Lost Creek, the company increased pounds drummed by 65% year-over-year and improved well field flow rates, capturing 40% more pounds [4][5] - The inventory at Lost Creek increased by 21% to 406,000 pounds [4] - At Shirley Basin, the estimated post-tax net cash flow is $119 million, with an NPV of $82 million and an internal rate of return of 69% [7] Market Data and Key Metrics Changes - The company has contracted for sales of 1.3 million pounds in 2026, with plans to cover these sales from existing inventory and new production [12] - The combined estimated mineral resource totals 21 million pounds in the measured indicated categories and 10.4 million pounds in the inferred category as of December 31, 2025 [11] Company Strategy and Development Direction - The company is focused on ramping up production at Lost Creek and bringing the Shirley Basin facility online, with significant progress made in construction [6][11] - The company aims to expand its resource base through ongoing drilling and exploration, particularly at the Lost Soldier and North Hadsell projects [10][11] - The management emphasizes the importance of maintaining a strong balance sheet to fund growth initiatives and capitalize on market opportunities [9][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in meeting delivery commitments for 2026, citing strong operational ramp-up at Lost Creek and positive progress at Shirley Basin [14][15] - The company is optimistic about the uranium market fundamentals and increased demand for secure U.S. uranium supply [12] - Management noted that regulatory approvals for Shirley Basin are anticipated soon, with no significant delays expected [36][38] Other Important Information - The company grew its workforce by 55% in 2025, adding 56 new team members to support operations [7] - The company is actively monitoring regulatory changes and participating in discussions to minimize operational risks [85][87] Q&A Session Summary Question: Confidence in meeting delivery commitments - Management expressed confidence based on current operations at Lost Creek and construction progress at Shirley Basin, indicating a solid plan for meeting contractual sales [14][15] Question: Product loan repayment timeline - Management indicated multiple options for repaying a 250,000-pound loan due in November, including potential cash settlements [20][22] Question: Production trends at Lost Creek - Management noted a steady ramp-up in production, with recovery from a significant weather event in December and positive trends expected in Q1 [29][30] Question: Regulatory approval timeline for Shirley Basin - Management anticipates receiving regulatory approvals soon, with no significant delays expected [36][38] Question: Discrepancy between pounds drummed and captured - Management explained that power outages affected production levels, leading to discrepancies in Q4 [43][45] Question: Milestones for ramping up production - Management outlined expectations for continued ramp-up at Lost Creek and initial solution delivery at Shirley Basin, with a focus on operational efficiency [51][52]

Ur-Energy (NYSEAM:URG) Q4 2025 Earnings call March 11, 2026 03:00 PM ET Company ParticipantsAlex Ritchie - General Counsel and Corporate SecretaryAnthony Taglieri - Senior Associate of Equity Research on Metals and MiningHeiko Ihle - Managing Director of Equity ResearchJustin Chan - Director of Mining Equity Research and Head of ResearchMatt Gili - President and CEOMatthew Key - VP of Equity ResearchRyan Schierman - VP of Regulatory AffairsSteve Hatten - COOValerie Kimball - Director of Investor RelationsCo ...

Financial Data and Key Metrics Changes - The company ended 2025 with $123.9 million in cash, primarily due to the successful closing of 4.75% convertible senior notes [7] - The average cash cost per pound sold was $42.89, reflecting improved operational efficiency [4] - The company achieved a positive gross profit of $74,000, marking a significant milestone in operational improvement [8] Business Line Data and Key Metrics Changes - At Lost Creek, inventory increased by 21% year-over-year to 406,000 pounds, with pounds drummed rising by 65% compared to 2024 [3][4] - Well field flow rates improved, with a 40% increase in pounds captured and profit per pound sold rising by more than $12 [4] - At Shirley Basin, the initial processing plant construction is nearing completion, with a projected mine life of 9 years and an estimated resource of 8.8 million pounds [6] Market Data and Key Metrics Changes - The company has contracted for sales of 1.3 million pounds in 2026, which will be covered by existing inventory and new production [11] - The estimated post-tax net cash flow for Lost Creek increased to $442 million, approximately 45% more than previous estimates [4] Company Strategy and Development Direction - The company is focused on ramping up production at Lost Creek and bringing the Shirley Basin facility online, indicating a strategy of operational expansion and resource growth [10] - The company is exploring additional projects, including Lost Soldier and North Hadsell, to diversify production and expand its resource base [8][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in meeting delivery commitments for 2026, citing operational ramp-up at Lost Creek and progress at Shirley Basin [14] - The company is optimistic about benefiting from positive uranium market fundamentals and increased demand for secure U.S. uranium supply [11] Other Important Information - The company expanded its workforce by 55% in 2025, adding 56 new team members to support operations [6] - The company is actively monitoring regulatory changes and participating in discussions to ensure compliance and minimize operational risks [87][88] Q&A Session Summary Question: Confidence in meeting delivery commitments - Management highlighted the ramp-up of operations at Lost Creek and progress at Shirley Basin as key factors for confidence in meeting delivery commitments [14] Question: Product loan repayment timeline - Management indicated multiple options for repaying a $250,000 loan, including purchasing pounds on the spot market [21][22] Question: Production trends at Lost Creek - Management noted a steady ramp-up at Lost Creek, with recovery from a significant weather event impacting production in December [30][31] Question: Regulatory approval timeline for Shirley Basin - Management anticipates receiving regulatory approvals soon, with no indications of delays [36][38] Question: Discrepancy between pounds drummed and captured - Management explained that power outages affected production levels, leading to discrepancies between pounds drummed and captured [45] Question: Future sales commitments and M&A strategy - Management is focusing on opportunities for 2029 and beyond, with no immediate need for M&A but recognizing the value of adding resources [71][72] Question: Demand for longer-term pricing - Management noted growing interest in securing uranium supplies, with a shift towards market-related contracts [78][80]

Financial Data and Key Metrics Changes - Revenues for Q4 2025 were $109.4 million, a 4% increase from $105.3 million in Q4 2024. For the full year, revenues were $434 million, a 10% increase from $393 million in 2024 [6] - Interest income on the fair value portfolio increased by 16% year-over-year, contributing significantly to total revenues [6] - Expenses for Q4 2025 were $102.2 million, a 4% increase from $98 million in Q4 2024. For the full year, expenses were $406 million, an 11% increase from $366 million in 2024 [8] - Pre-tax earnings for Q4 2025 were $7.2 million, slightly down from $7.4 million in Q4 2024. Full year pre-tax earnings were $28 million, up from $27.4 million in 2024 [9][10] - Net income for Q4 2025 was $5 million, compared to $5.1 million in Q4 2024. For the full year, net income was $19.3 million, slightly up from $19.2 million in 2024 [10] Business Line Data and Key Metrics Changes - The loan portfolio increased by 15% year-over-year, contributing to higher securitization debt [9] - The fair value portfolio grew to $3.6 billion, yielding 11.4% net of expected losses [6] - The company originated $363 million of new contracts in Q4 2025, with a total of $1.638 billion for the full year, slightly down from $1.682 billion in 2024 [14] Market Data and Key Metrics Changes - The total delinquency rate greater than 30 days for 2025 was 14.77%, a slight improvement from 14.85% in 2024 [21] - Annualized net charge-offs for 2025 were 7.76%, compared to 7.62% in 2024 [21] - The company remains among the best credit performers in the subprime space, as indicated by Intex data [23] Company Strategy and Development Direction - The company aims to focus on growth in 2026, improving margins through better interest rates and enhancing overall portfolio performance by eliminating underperforming loans from 2022 and 2023 [30][31] - A new credit scoring model utilizing AI and machine learning has increased approval rates by 11% [17] - The company is expanding its dealer network and increasing monthly applications from 250,000 to 325,000 [16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the interest rate environment, suggesting rates may decrease, which would positively impact margins [29][30] - The company noted macroeconomic challenges such as inflation and stagnant wage growth but highlighted effective collection techniques that have helped maintain portfolio performance [22] - Overall, management is confident about the company's position and growth potential moving into 2026 [30][31] Other Important Information - The company signed a new warehouse line with Capital One for $150 million and a $900 million Prime Forward Flow commitment, which are expected to support growth in 2026 [3][4] - Shareholders' equity increased by 6% to $309.5 million, marking an all-time high [11] Q&A Session Summary - No specific questions or answers were provided in the content, thus this section is not applicable.